Connect your AI

aTyr Pharma ATYR Total Current Assets

Total Current Assets at other companies

Bristol-Myers SquibbBMY

$27.21B-11.6%

Merck & Co.MRK

$35.02B-1.4%

United TherapeuticsUTHR

$2.87B-27.1%

Design Therapeutics, Inc.DSGN

$227.05M-2.8%

Oric Pharmaceuticals, Inc.ORIC

$290.23M+37.3%

Vor BiopharmaVOR

$500.78M+672%

Other financials

Income statement

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Reported directly by aTyr Pharma in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is aTyr Pharma's total current assets?: aTyr Pharma (ATYR) reported total current assets of $67.58M in Q1 2026.
How has aTyr Pharma's total current assets changed year-over-year?: aTyr Pharma's total current assets decreased by 18.8% year-over-year, from $83.27M to $67.58M.
What is the long-term trend for aTyr Pharma's total current assets?: Over 5 years (2020 to 2025), aTyr Pharma's total current assets has grown at a 17.7% compound annual growth rate (CAGR), from $35.53M to $80.24M.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.